Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 3/2018

11.04.2018 | Original Article

Patterns of Care of Breast Cancer Patients in a Rural Cancer Center in Western India

verfasst von: Bhagwan M. Nene, Farida Selmouni, Manoj Lokhande, Sanjay J. Hingmire, Richard Muwonge, Kasturi Jayant, Rengaswamy Sankaranarayanan

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is an emerging public health problem in low- and middle-income countries. The main objective is to describe the clinical characteristics and patterns of care of breast cancer patients diagnosed and treated in a rural cancer hospital in Barshi, Western India. The results from a cross-sectional study of 99 consecutive breast cancer patients diagnosed and treated between February 2012 and November 2014 in Nargis Dutt Memorial Cancer Hospital is reported. The case records of the patients were scrutinized and reviewed to abstract data on their clinical characteristics, diagnostic, and treatment details. The mean age at diagnosis of the patients was 52.8 ± 11.6 years; 83.5% of women were married, and 60.6% were illiterate. Sixty percent of patients had tumors measuring 5 cm or less. Almost half of the patients (46.4%) had stage I or II A disease and a third (36.0%) had axillary lymph node metastasis. Estrogen, progesterone, and human epidermal growth factor receptor2 receptor status were investigated in 41 (41.4%) of patients only. The median interval between diagnosis and initiation of treatment was 11 days. Modified radical mastectomy was done in 91% of patients, and nearly a third of patients who were prescribed chemotherapy did not complete treatment. The rural-based tertiary cancer care center has made treatment more accessible to breast cancer patients and has reduced the interval between diagnosis and treatment initiation. However, there are still many challenges like non-compliance to and incomplete treatments and poor follow-up that need to be addressed.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet}. International Agency for Research on Cancer, Lyon Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet}. International Agency for Research on Cancer, Lyon
2.
Zurück zum Zitat Hortobagyi GN, de la Garza SJ, Pritchard K, Amadori D, Haidinger R, Hudis CA et al (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6:391–401CrossRefPubMed Hortobagyi GN, de la Garza SJ, Pritchard K, Amadori D, Haidinger R, Hudis CA et al (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6:391–401CrossRefPubMed
3.
Zurück zum Zitat Anderson BO, Jakesz R (2008) Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg 32:2578–2585CrossRefPubMed Anderson BO, Jakesz R (2008) Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg 32:2578–2585CrossRefPubMed
4.
Zurück zum Zitat Porter P (2008) “Westernizing” women’s risks? Breast cancer in lower-income countries. N Engl J Med 358:213–216CrossRefPubMed Porter P (2008) “Westernizing” women’s risks? Breast cancer in lower-income countries. N Engl J Med 358:213–216CrossRefPubMed
5.
Zurück zum Zitat Green M, Raina V (2008) Epidemiology, screening and diagnosis of breast cancer in the Asia Pacific Region: current perspectives and important considerations. Asia Pac J Clin Oncol 4:S5–S13CrossRef Green M, Raina V (2008) Epidemiology, screening and diagnosis of breast cancer in the Asia Pacific Region: current perspectives and important considerations. Asia Pac J Clin Oncol 4:S5–S13CrossRef
6.
Zurück zum Zitat Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040CrossRefPubMed Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040CrossRefPubMed
7.
Zurück zum Zitat Nandakumar A, Anantha N, Venugopal TC, Sankaranarayanan R, Thimmasetty K, Dhar M (1995) Survival in breast cancer: a population-based study in Bangalore, India. Int J Cancer 60:593–596CrossRefPubMed Nandakumar A, Anantha N, Venugopal TC, Sankaranarayanan R, Thimmasetty K, Dhar M (1995) Survival in breast cancer: a population-based study in Bangalore, India. Int J Cancer 60:593–596CrossRefPubMed
8.
Zurück zum Zitat Indian Council of Medical Research (2001) National Cancer Registry Programme. Consolidated report of the population based cancer registries 1990-96. Incidence and Distribution of Cancer. Indian Council of Medical Research, New Delhi Indian Council of Medical Research (2001) National Cancer Registry Programme. Consolidated report of the population based cancer registries 1990-96. Incidence and Distribution of Cancer. Indian Council of Medical Research, New Delhi
9.
Zurück zum Zitat Agarwal G, Ramakant P (2008) Breast cancer care in India: the current scenario and the challenges for the future. Breast Care (Basel) 3:21–27CrossRef Agarwal G, Ramakant P (2008) Breast cancer care in India: the current scenario and the challenges for the future. Breast Care (Basel) 3:21–27CrossRef
10.
Zurück zum Zitat Khokhar A (2012) Breast cancer in India: where do we stand and where do we go? Asian Pac J Cancer Prev 13:4861–4866CrossRefPubMed Khokhar A (2012) Breast cancer in India: where do we stand and where do we go? Asian Pac J Cancer Prev 13:4861–4866CrossRefPubMed
11.
Zurück zum Zitat Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010) Profile of breast cancer patients at a tertiary care hospital in North India. Indian J Cancer 47:16–22CrossRefPubMed Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010) Profile of breast cancer patients at a tertiary care hospital in North India. Indian J Cancer 47:16–22CrossRefPubMed
12.
Zurück zum Zitat Chandra AB (1979) Problems and prospects of cancer of the breast in India. J Indian Med Assoc 72:43–45PubMed Chandra AB (1979) Problems and prospects of cancer of the breast in India. J Indian Med Assoc 72:43–45PubMed
13.
Zurück zum Zitat Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784–1792CrossRefPubMed Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784–1792CrossRefPubMed
14.
Zurück zum Zitat Kingsmore D, Hole D, Gillis C (2004) Why does specialist treatment of breast cancer improve survival? The role of surgical management. Br J Cancer 90:1920–1925CrossRefPubMedPubMedCentral Kingsmore D, Hole D, Gillis C (2004) Why does specialist treatment of breast cancer improve survival? The role of surgical management. Br J Cancer 90:1920–1925CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gangane N, Ng N, Sebastian MS (2015) Women’s knowledge, attitudes, and practices about breast cancer in a rural district of Central India. Asian Pac J Cancer Prev 16:6863–6870CrossRefPubMed Gangane N, Ng N, Sebastian MS (2015) Women’s knowledge, attitudes, and practices about breast cancer in a rural district of Central India. Asian Pac J Cancer Prev 16:6863–6870CrossRefPubMed
16.
Zurück zum Zitat Hebert JR, Ghumare SS, Gupta PC (2006) Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev 7:547–555PubMed Hebert JR, Ghumare SS, Gupta PC (2006) Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev 7:547–555PubMed
17.
Zurück zum Zitat Sainsbury R, Haward B, Rider L, Johnston C, Round C (1995) Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 345:1265–1270CrossRefPubMed Sainsbury R, Haward B, Rider L, Johnston C, Round C (1995) Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 345:1265–1270CrossRefPubMed
18.
Zurück zum Zitat Hebert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R (2005) Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104:1343–1348CrossRefPubMed Hebert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R (2005) Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104:1343–1348CrossRefPubMed
19.
Zurück zum Zitat Sobin LH, Gospodarowicz MK (2009) TNM Classification of malignant tumours. International Union Against Cancer, Geneva Sobin LH, Gospodarowicz MK (2009) TNM Classification of malignant tumours. International Union Against Cancer, Geneva
20.
Zurück zum Zitat Harford JB (2011) Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 12:306–312CrossRefPubMed Harford JB (2011) Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 12:306–312CrossRefPubMed
21.
Zurück zum Zitat Mittra I, Badwe RA, Desai PB, Yeole BB, Jussawalla DJ (1989) Early detection of breast cancer in developing countries. Lancet 1:719–720CrossRefPubMed Mittra I, Badwe RA, Desai PB, Yeole BB, Jussawalla DJ (1989) Early detection of breast cancer in developing countries. Lancet 1:719–720CrossRefPubMed
22.
Zurück zum Zitat Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS (2005) Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India—a cross-sectional study. World J Surg Oncol 3:67CrossRefPubMedPubMedCentral Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS (2005) Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India—a cross-sectional study. World J Surg Oncol 3:67CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS et al (2010) Is breast cancer the same disease in Asian and Western countries? World J Surg 34:2308–2324CrossRefPubMedPubMedCentral Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS et al (2010) Is breast cancer the same disease in Asian and Western countries? World J Surg 34:2308–2324CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Das D, Pathak M (2012) The growing rural-urban disparity in India: some issues. Int J Adv Res Technol 1:145–151 Das D, Pathak M (2012) The growing rural-urban disparity in India: some issues. Int J Adv Res Technol 1:145–151
25.
Zurück zum Zitat Sharma K, Costas A, Shulman LN, Meara JG (2012) A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol 2012:121873CrossRefPubMedPubMedCentral Sharma K, Costas A, Shulman LN, Meara JG (2012) A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol 2012:121873CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Aziz Z, Iqbal J, Akram M (2008) Effect of social class disparities on disease stage, quality of treatment and survival outcomes in breast cancer patients from developing countries. Breast J 14:372–375CrossRefPubMed Aziz Z, Iqbal J, Akram M (2008) Effect of social class disparities on disease stage, quality of treatment and survival outcomes in breast cancer patients from developing countries. Breast J 14:372–375CrossRefPubMed
27.
Zurück zum Zitat Cross CK, Harris J, Recht A (2002) Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer 95:1988–1999CrossRefPubMed Cross CK, Harris J, Recht A (2002) Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer 95:1988–1999CrossRefPubMed
28.
Zurück zum Zitat Burgess CC, Potts HW, Hamed H, Bish AM, Hunter MS, Richards MA et al (2006) Why do older women delay presentation with breast cancer symptoms? Psychooncology 15:962–968CrossRefPubMed Burgess CC, Potts HW, Hamed H, Bish AM, Hunter MS, Richards MA et al (2006) Why do older women delay presentation with breast cancer symptoms? Psychooncology 15:962–968CrossRefPubMed
29.
Zurück zum Zitat Pineros M, Sanchez R, Cendales R, Perry F, Ocampo R (2009) Patient delay among Colombian women with breast cancer. Salud Publica Mex 51:372–380CrossRefPubMed Pineros M, Sanchez R, Cendales R, Perry F, Ocampo R (2009) Patient delay among Colombian women with breast cancer. Salud Publica Mex 51:372–380CrossRefPubMed
30.
Zurück zum Zitat Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81:646–649CrossRefPubMedPubMedCentral Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81:646–649CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Agarwal G, Ramakant P, Forgach ER, Rendon JC, Chaparro JM, Basurto CS et al (2009) Breast cancer care in developing countries. World J Surg 33:2069–2076CrossRefPubMed Agarwal G, Ramakant P, Forgach ER, Rendon JC, Chaparro JM, Basurto CS et al (2009) Breast cancer care in developing countries. World J Surg 33:2069–2076CrossRefPubMed
32.
Zurück zum Zitat Jones CE, Maben J, Jack RH, Davies EA, Forbes LJ, Lucas G et al (2014) A systematic review of barriers to early presentation and diagnosis with breast cancer among black women. BMJ Open 4:e004076CrossRefPubMedPubMedCentral Jones CE, Maben J, Jack RH, Davies EA, Forbes LJ, Lucas G et al (2014) A systematic review of barriers to early presentation and diagnosis with breast cancer among black women. BMJ Open 4:e004076CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Robertson R, Campbell NC, Smith S, Donnan PT, Sullivan F, Duffy R, Ritchie LD, Millar D, Cassidy J, Munro A (2004) Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 90:1479–1485CrossRefPubMedPubMedCentral Robertson R, Campbell NC, Smith S, Donnan PT, Sullivan F, Duffy R, Ritchie LD, Millar D, Cassidy J, Munro A (2004) Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 90:1479–1485CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Donkor A, Lathlean J, Wiafe S, Vanderpuye V, Fenlon D, Yarney J et al (2015) Factors contributing to late presentation of breast cancer in Africa: a systematic literature review. Arch Med 8:1–10 Donkor A, Lathlean J, Wiafe S, Vanderpuye V, Fenlon D, Yarney J et al (2015) Factors contributing to late presentation of breast cancer in Africa: a systematic literature review. Arch Med 8:1–10
35.
Zurück zum Zitat Varughese J, Richman S (2010) Cancer care inequity for women in resource-poor countries. Rev Obstet Gynecol 3:122–132PubMedPubMedCentral Varughese J, Richman S (2010) Cancer care inequity for women in resource-poor countries. Rev Obstet Gynecol 3:122–132PubMedPubMedCentral
36.
Zurück zum Zitat Montella M, Crispo A, Botti G, De MM, de BG, Fabbrocini G et al (2001) An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Breast Cancer Res Treat 66:209–215CrossRefPubMed Montella M, Crispo A, Botti G, De MM, de BG, Fabbrocini G et al (2001) An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Breast Cancer Res Treat 66:209–215CrossRefPubMed
37.
Zurück zum Zitat Sofi GN, Sofi JN, Nadeem R, Shiekh RY, Khan FA, Sofi AA, Bhat HA, Bhat RA (2012) Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev 13:5047–5052CrossRefPubMed Sofi GN, Sofi JN, Nadeem R, Shiekh RY, Khan FA, Sofi AA, Bhat HA, Bhat RA (2012) Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev 13:5047–5052CrossRefPubMed
38.
Zurück zum Zitat Zubeda S, Kaipa PR, Shaik NA, Mohiuddin MK, Vaidya S, Pavani B, Srinivasulu M, Latha MM, Hasan Q (2013) Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India. Asian Pac J Cancer Prev 14:2231–2235CrossRefPubMed Zubeda S, Kaipa PR, Shaik NA, Mohiuddin MK, Vaidya S, Pavani B, Srinivasulu M, Latha MM, Hasan Q (2013) Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India. Asian Pac J Cancer Prev 14:2231–2235CrossRefPubMed
39.
Zurück zum Zitat Francis GD, Dimech M, Giles L, Hopkins A (2007) Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program. J Clin Pathol 60:1277–1283CrossRefPubMedPubMedCentral Francis GD, Dimech M, Giles L, Hopkins A (2007) Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program. J Clin Pathol 60:1277–1283CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD (2000) Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol 53:688–696CrossRefPubMedPubMedCentral Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD (2000) Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol 53:688–696CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Kuraparthy S, Reddy KM, Yadagiri LA, Yutla M, Venkata PB, Kadainti SV et al (2007) Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in southern India. World J Surg Oncol 5:56CrossRefPubMedPubMedCentral Kuraparthy S, Reddy KM, Yadagiri LA, Yutla M, Venkata PB, Kadainti SV et al (2007) Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in southern India. World J Surg Oncol 5:56CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V, Badwe R, Chinoy RF (2009) Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is? Indian J Pathol Microbiol 52:171–174CrossRefPubMed Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V, Badwe R, Chinoy RF (2009) Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is? Indian J Pathol Microbiol 52:171–174CrossRefPubMed
43.
Zurück zum Zitat Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A (2009) Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer 125:1663–1670CrossRefPubMed Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A (2009) Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer 125:1663–1670CrossRefPubMed
44.
Zurück zum Zitat Manjunath S, Prabhu JS, Kaluve R, Correa M, Sridhar TS (2011) Estrogen receptor negative breast cancer in India: do we really have higher burden of this subtype? Indian J Surg Oncol 2:122–125CrossRefPubMedPubMedCentral Manjunath S, Prabhu JS, Kaluve R, Correa M, Sridhar TS (2011) Estrogen receptor negative breast cancer in India: do we really have higher burden of this subtype? Indian J Surg Oncol 2:122–125CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Kumar V, Tewari M, Singh U, Shukla HS (2007) Significance of Her-2/neu protein over expression in Indian breast cancer patients. Indian J Surg 69:122–128CrossRefPubMed Kumar V, Tewari M, Singh U, Shukla HS (2007) Significance of Her-2/neu protein over expression in Indian breast cancer patients. Indian J Surg 69:122–128CrossRefPubMed
46.
Zurück zum Zitat Munjal K, Ambaye A, Evans MF, Mitchell J, Nandedkar S, Cooper K (2009) Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients. Asian Pac J Cancer Prev 10:773–778PubMed Munjal K, Ambaye A, Evans MF, Mitchell J, Nandedkar S, Cooper K (2009) Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients. Asian Pac J Cancer Prev 10:773–778PubMed
47.
Zurück zum Zitat Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45CrossRefPubMed Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45CrossRefPubMed
48.
Zurück zum Zitat Aggarwal V, Agarwal G, Lal P, Krishnani N, Mishra A, Verma AK, Mishra SK (2008) Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins. World J Surg 32:2562–2569CrossRefPubMed Aggarwal V, Agarwal G, Lal P, Krishnani N, Mishra A, Verma AK, Mishra SK (2008) Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins. World J Surg 32:2562–2569CrossRefPubMed
49.
Zurück zum Zitat Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784CrossRefPubMed Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784CrossRefPubMed
50.
Zurück zum Zitat Early Breast Cancer Trialists' Collaborative (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717CrossRef Early Breast Cancer Trialists' Collaborative (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717CrossRef
Metadaten
Titel
Patterns of Care of Breast Cancer Patients in a Rural Cancer Center in Western India
verfasst von
Bhagwan M. Nene
Farida Selmouni
Manoj Lokhande
Sanjay J. Hingmire
Richard Muwonge
Kasturi Jayant
Rengaswamy Sankaranarayanan
Publikationsdatum
11.04.2018
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 3/2018
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-018-0748-4

Weitere Artikel der Ausgabe 3/2018

Indian Journal of Surgical Oncology 3/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.